Finding the right weight loss medication feels overwhelming. You’ve probably already tried the diets, the gym routines, the calorie counting — and you’re still here, researching injections at whatever hour this is, wondering which one actually works and whether any of it is safe.
→ Book your blood test at HealthDeliver: Open daily 08:00–18:30 · Asoke, Sathorn, Phrom Phong, or home collection
The good news: all five of the most effective prescription weight loss medications in the world are available in Bangkok right now, and the clinical evidence behind them is genuinely impressive. The less straightforward news: they’re not interchangeable. Ozempic, Mounjaro, Wegovy, Saxenda, and Rybelsus work differently, suit different patients, and produce different results. Picking the wrong one — or getting one without medical supervision — can mean poor results at best and real health risks at worst.
This guide, written and reviewed by our doctors at HealthDeliver Clinic Bangkok, breaks down exactly how each medication works, who it’s right for, what results clinical trials actually show, and how they compare on side effects and cost. By the end you’ll know which conversation to have with your doctor — and why that conversation matters more than which medication you’ve already decided you want.
All five are available at HealthDeliver. All five require a proper medical assessment before prescription. That’s not a bureaucratic hurdle — it’s what keeps you safe and ensures the medication you start is the one most likely to work for your specific physiology.
Weight Loss Medication — comparison at a glance
| Ozempic | Mounjaro | Wegovy | Saxenda | Rybelsus | |
|---|---|---|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide | Semaglutide | Liraglutide | Semaglutide |
| How taken | Weekly injection | Weekly injection | Weekly injection | Daily injection | Daily tablet |
| Approved for | Type 2 diabetes | Type 2 diabetes + weight | Weight management | Weight management | Type 2 diabetes |
| Avg. weight loss | 9–15% | 15–22% | ~15% | 5–8% | 5–10% |
| User rating | — | — | — | 7.5/10 | 6.4/10 |
| Best for | Diabetes + weight | Maximum results | Weight-focused | Daily preference | Needle-averse |
All figures from published clinical trials. Individual results vary. All medications require a prescription and doctor assessment.
What they all have in common
All five medications belong to the GLP-1 receptor agonist class — they work by mimicking a hormone your body naturally produces after eating. This slows digestion, reduces appetite, and helps regulate blood sugar. The result is that you feel fuller on less food, and your body becomes more efficient at managing glucose.
The key differences between them are which hormones they target, how often you take them, and how strong the weight loss effect is in clinical trials.
None of them are a substitute for lifestyle changes. All of them require a prescription and medical supervision. None should be purchased without a consultation — both for safety and because the wrong medication for your health profile can cause serious side effects.
Ozempic (semaglutide) — weekly injection
Ozempic is the most well-known GLP-1 medication and the most commonly prescribed starting point. It contains semaglutide and is approved for type 2 diabetes, with substantial evidence supporting its off-label use for weight management.
How it works: Targets GLP-1 receptors to reduce appetite, slow gastric emptying, and improve blood sugar control.
Dosing: Starts at 0.25mg weekly, titrated to 0.5mg then 1mg based on response and tolerance.
Average weight loss: 9–15% of body weight over 68 weeks when combined with lifestyle changes. Around 50% of users lose at least 15%.
Best for: Patients with type 2 diabetes or insulin resistance. Those new to GLP-1 therapy. Patients who want an established, well-researched option.
Not suitable for: Type 1 diabetes, personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2.
→ Full details and Bangkok pricing Ozempic
Mounjaro (tirzepatide) — weekly injection
Mounjaro is the newest and most clinically powerful option currently available. Unlike the others, it targets two hormones — GLP-1 and GIP — simultaneously. This dual action produces stronger appetite suppression and significantly greater weight loss than semaglutide alone.
How it works: Activates both GLP-1 and GIP receptors, improving insulin sensitivity, reducing appetite more aggressively, and supporting greater fat loss.
Dosing: Starts at 2.5mg weekly, titrated up to a maximum of 15mg based on response.
Average weight loss: 15–22% of body weight in clinical trials — the highest of any prescription medication currently available. Some participants lost over 25%.
Best for: Patients wanting maximum weight loss results. Those who haven’t responded well to semaglutide. Patients with significant insulin resistance or type 2 diabetes where stronger metabolic control is needed.
Not suitable for: Personal or family history of medullary thyroid carcinoma or MEN2. Requires careful monitoring — your doctor will assess suitability.
→ Full details and Bangkok pricing: Mounjaro
Wegovy (semaglutide 2.4mg) — weekly injection
Wegovy uses the same active ingredient as Ozempic — semaglutide — but at a higher dose specifically approved for chronic weight management rather than diabetes. It follows the same mechanism but is dosed more aggressively for greater weight loss effect.
How it works: Same GLP-1 receptor agonist mechanism as Ozempic. The higher dose produces stronger appetite suppression.
Dosing: Titrated over 16 weeks from 0.25mg up to the 2.4mg maintenance dose.
Average weight loss: Approximately 15% of body weight in clinical trials — comparable to Ozempic at maximum dose but officially approved for weight rather than diabetes.
Best for: Patients without diabetes who want a medication specifically approved for weight management. Those who have already used Ozempic and want to step up to a higher semaglutide dose. Patients whose primary goal is weight rather than blood sugar control.
→ Full details and Bangkok pricing: Wegovy
Saxenda (liraglutide) — daily injection
Saxenda was one of the first GLP-1 medications approved specifically for weight management and remains a widely used, well-established option. It contains liraglutide rather than semaglutide, and is injected daily rather than weekly.
How it works: GLP-1 receptor agonist — same class as the others, but with liraglutide as the active ingredient. Enhances feelings of fullness and reduces appetite.
Dosing: Starts at 0.6mg daily, titrated weekly up to a maximum of 3.0mg daily.
Average weight loss: 5–8% of body weight. Around 50% of users lose at least 5%, and approximately 18% lose 10% or more.
User rating: 7.5/10 based on patient-reported outcomes — higher than Rybelsus and reflecting good tolerability.
Best for: Patients who prefer or are more comfortable with a daily routine. Those for whom weekly injections aren’t suitable. Patients with a previous positive experience on Saxenda. Those who can’t access or tolerate semaglutide-based medications.
Note: Saxenda produces less average weight loss than Ozempic, Mounjaro, or Wegovy. Your doctor will discuss whether the trade-off suits your situation.
→ Full details and Bangkok pricing: Saxenda
Rybelsus (oral semaglutide) — daily tablet
Rybelsus is the only oral GLP-1 medication in this class. It contains the same active ingredient as Ozempic and Wegovy — semaglutide — but in tablet form. It’s the right choice for patients who are needle-averse or who strongly prefer not to inject.
How it works: Same semaglutide mechanism as Ozempic and Wegovy. The oral formulation has lower bioavailability than injections, which is why the weight loss effect is somewhat less pronounced.
Dosing: 3mg daily for the first month, increasing to 7mg, then 14mg if needed. Must be taken on an empty stomach with a small sip of plain water — no food or other medication for 30 minutes after.
Average weight loss: 5–10% of body weight. Less than the injectable semaglutide options due to lower absorption.
User rating: 6.4/10 — effective but the administration requirements (empty stomach, timing) can affect consistency.
Best for: Patients who want to avoid injections entirely. Those managing type 2 diabetes who prefer an oral format. Patients who are willing to accept a moderately lower weight loss outcome in exchange for no needles.
→ Full details and Bangkok pricing: Rybelsus
Side effects — what to expect across all five
All five medications share a similar side effect profile because they work through the same hormonal pathway.
Common side effects (all five):
- Nausea — most common, especially in the first few weeks
- Vomiting
- Diarrhea or constipation
- Abdominal discomfort
These typically improve as your body adjusts to the medication. Starting at a low dose and titrating slowly — which is standard practice at HealthDeliver — significantly reduces their severity.
Serious side effects (rare but important to know):
- Pancreatitis — stop the medication and seek medical attention if you have severe, persistent abdominal pain
- Gallbladder issues — particularly with Saxenda and Ozempic
- Thyroid C-cell changes — all GLP-1 medications carry a warning; avoid if you have a personal or family history of medullary thyroid carcinoma
- Hypoglycaemia — more relevant for patients also taking insulin or sulphonylureas
Important: Tell your doctor about all medications you’re taking before starting any of these. Combination with other diabetes medications in particular requires careful management.
Can you switch between medications?
Yes, but not without medical guidance. Switching from one GLP-1 to another — for example from Saxenda to Ozempic, or from Ozempic to Mounjaro — requires a transition plan. Your doctor will advise on whether a washout period is needed, how to adjust dosing, and what to monitor during the switch.
Do not take two GLP-1 medications simultaneously. They act on the same receptors and combining them significantly increases the risk of side effects without proportional benefit.
Which one should you choose?
There’s no universal right answer — the best medication is the one that matches your health profile, your goals, and your lifestyle. As a general starting framework:
Choose Mounjaro if you want the strongest possible weight loss effect and your doctor confirms you’re a suitable candidate.
Choose Wegovy if you don’t have diabetes and want a semaglutide medication specifically approved for weight management.
Choose Ozempic if you have type 2 diabetes or insulin resistance and want an established, well-researched GLP-1 option.
Choose Saxenda if you prefer daily dosing, have used it previously, or weekly semaglutide injections aren’t suitable for you.
Choose Rybelsus if you want to avoid injections entirely and are comfortable with a slightly lower average weight loss outcome.
Your doctor at HealthDeliver will assess your BMI, health history, metabolic markers, and any current medications before making a recommendation. No medication is prescribed without this assessment.
Why HealthDeliver for weight loss in Bangkok?
We’re not a pharmacy that dispenses whatever you ask for. We’re a doctor-led clinic that happens to have three locations across Bangkok, same-day appointments, and English-speaking GPs who have prescribed and monitored GLP-1 medications for hundreds of patients — expats, tourists, long-term residents, and Thais alike.
Here’s what that means in practice.
Every patient starts with a full medical assessment. We review your health history, current medications, metabolic markers, and weight loss history before recommending anything. If a medication isn’t right for you, we’ll tell you — and explain what is.
We prescribe genuine medication from licensed Thai distributors only. No grey market product, no unverified sources, no shortcuts. Every pen and every tablet we dispense is the real thing.
We monitor you through the process. GLP-1 medications work best — and are safest — when someone is tracking your response, adjusting your dose, and catching side effects early. That’s what our follow-up appointments are for.
And when you reach your goal weight, we don’t just wave goodbye. We build a maintenance strategy from the start, because the research is clear: the patients who keep the weight off are the ones who had a plan for when treatment ends.
Three clinics. Open daily. Most patients seen within 24 hours.
→ Book your blood test at HealthDeliver: Open daily 08:00–18:30 · Asoke, Sathorn, Phrom Phong, or home collection
The bottom line
The best weight loss medication is the one that matches your body, your health history, and your life — not the one with the most Instagram posts about it or the cheapest price you found online.
Mounjaro produces the most dramatic results in trials. Ozempic has the longest track record. Wegovy is specifically approved for weight rather than diabetes. Saxenda suits patients who prefer daily dosing. Rybelsus removes needles from the equation entirely. All of them work. None of them work in isolation — they work as part of a medically supervised program that includes monitoring, nutritional support, and a long-term plan.
If you’ve read this far, you’re already thinking about this more carefully than most. The next step is a conversation with a doctor who can look at your specific situation — your BMI, your blood work, your history — and tell you which of these five is actually right for you.
That conversation takes about 30–45 minutes at HealthDeliver. It could change the next several years of your life.
→ Book your blood test at HealthDeliver: Open daily 08:00–18:30 · Asoke, Sathorn, Phrom Phong, or home collection
Frequently asked questions
Do I need a prescription for any of these medications in Thailand?
Yes. All five are prescription-only in Thailand. A doctor consultation is required before any can be dispensed.
Can I get these medications delivered in Bangkok?
Yes. Once prescribed, Bangkok delivery can be arranged for most medications. Contact our care team to confirm availability.
Which medication produces the most weight loss?
Mounjaro (tirzepatide) produces the highest average weight loss in clinical trials — 15–22% of body weight. Wegovy and Ozempic follow at around 15% and 9–15% respectively. Saxenda and Rybelsus typically produce 5–10%.
Can tourists or expats access these medications in Bangkok?
Yes, subject to medical assessment. We regularly see patients visiting Thailand for short or extended stays.
What is the cost of these medications in Bangkok?
Pricing varies by medication and dose. Visit the individual medication pages for current pricing, or contact our care team directly.
Can I take two of these medications at the same time?
No. Taking two GLP-1 medications simultaneously is not recommended and increases the risk of serious side effects.
How long do I need to take these medications?
Weight regain is common when treatment stops without a maintenance plan. Your doctor will discuss a long-term strategy from the start — including how and when to reduce or stop medication safely.
The clinical evidence — what the research actually shows
We cite numbers throughout this article. Here’s where they come from.
The 15% average weight loss figure for semaglutide (Ozempic/Wegovy) comes from the STEP 1 trial, published in the New England Journal of Medicine in 2021, which followed 1,961 adults over 68 weeks. [NEJM, 2021 — link: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183]
The 15–22% figure for tirzepatide (Mounjaro) comes from the SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, which followed 2,539 adults over 72 weeks. At the highest dose, 57% of participants lost more than 20% of body weight. [NEJM, 2022 — link: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038]
The cardiovascular benefit data referenced in this article comes from a large observational study of approximately 2.4 million individuals published in Nature Medicine in 2025, which found reduced rates of heart attacks and strokes among GLP-1 users. [Nature Medicine, 2025 — link: https://www.nature.com/articles/s41591-024-03285-3]
The 5–8% figure for liraglutide (Saxenda) comes from the SCALE Obesity and Prediabetes trial published in the New England Journal of Medicine in 2015. [NEJM, 2015 — link: https://www.nejm.org/doi/full/10.1056/NEJMoa1411892]
HealthDeliver’s clinical team reviews emerging evidence on GLP-1 medications on an ongoing basis. This article was last reviewed by Dr. Pimsupa Puthipiroj in May 2026.
